Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,671.00    -46.00 (-0.98%)
Bid:
4,669.00
Ask:
4,670.00
Spread: 1.00 (0.021%)
Market Cap: £100.88b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Board and Committee Changes

6 Feb 2024 07:00

RNS Number : 0508C
British American Tobacco PLC
06 February 2024
 

?February 2024

British American Tobacco p.l.c. (the 'Company')

Board and Committee Changes

The Company announces that Sue Farr and Dimitri Panayotopoulos will step down from the Board with effect from the conclusion of the Company's AGM on 24 April 2024 having served as Non-Executive Directors for nine years.

As a result of these departures, the Company announces changes to the role of Senior Independent Director and to the composition of the Audit and Remuneration Committees.

With effect from the conclusion of the Company's AGM on 24 April 2024:

- Holly Keller Koeppel will be appointed as Senior Independent Director, succeeding Sue Farr. Holly has been a Non-Executive Director of the Company since July 2017 and she is currently Chair of the Audit Committee and a member of the Nominations Committee.

 

- Darrell Thomas will be appointed as Chair of the Audit Committee, succeeding Holly Keller Koeppel, who will remain a member of the Audit Committee.

 

- Kandy Anand will be appointed as Chair of the Remuneration Committee, succeeding Dimitri Panayotopoulos.

Commenting of the changes, Luc Jobin, said: "I would like to thank both Sue and Dimitri for their extensive contribution to the Board over their tenures. I would also like to thank Holly for chairing the Audit Committee since 2019. I look forward to welcoming Holly, Darrell and Kandy to their new roles."

From the conclusion of the 2024 AGM, the memberships of the Company's Audit and Remuneration Committees will be:

Audit Committee

Remuneration Committee

Chair: Darrell Thomas

Chair: Kandy Anand

Holly Keller Koeppel

Murray S. Kessler

Karen Guerra

Serpil Timuray

Véronique Laury

 

The above proposals are subject to re-election of each of the Directors at the 2024 AGM.

This announcement is made in accordance with LR 9.6.11.

Enquiries:

British American Tobacco Press Media Centre

+44 (0) 20 7845 2888 (24 hours) | @BATplc

Investor Relations

Victoria Buxton: +44 (0)20 7845 2012

Amy Chamberlain: +44 (0)20 7845 1124

Yetunde Ibe: +44 (0)20 7845 1095

John Harney: +44 (0)20 7845 1263

Jane Henderson: +44 (0)20 7845 1117

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGGZMKNGDZM
Date   Source Headline
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20261:00 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202612:20 pmRNSTotal Voting Rights
2nd Jan 202612:15 pmRNSBlock listing Interim Review
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20252:30 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:30 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20255:15 pmRNSDirector Declaration
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:05 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSBranch Register: Dividend Finalisation Information
12th Dec 20257:05 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSCommittee Change
11th Dec 202510:00 amRNSDirector Declaration
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:05 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSShare Buyback Programme
9th Dec 20257:05 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNS2025 H2 Pre-Close Trading Update
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:05 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSCompletion of Block Trade of ITC Hotels Shares
4th Dec 20252:30 pmRNSDirector/PDMR Shareholding
4th Dec 202512:15 pmRNSProposed Block Trade of ITC Hotels Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 202512:45 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20258:05 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.